1. Home
  2. NIO vs RDY Comparison

NIO vs RDY Comparison

Compare NIO & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NIO Inc. American depositary shares each  representing one ordinary share

NIO

NIO Inc. American depositary shares each representing one ordinary share

HOLD

Current Price

$4.78

Market Cap

12.8B

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$13.87

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NIO
RDY
Founded
2014
1984
Country
China
India
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.8B
11.6B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
NIO
RDY
Price
$4.78
$13.87
Analyst Decision
Buy
Strong Buy
Analyst Count
9
1
Target Price
$6.73
$16.90
AVG Volume (30 Days)
39.3M
1.1M
Earning Date
11-25-2025
01-22-2026
Dividend Yield
N/A
0.52%
EPS Growth
N/A
9.95
EPS
N/A
0.79
Revenue
$10,189,444,895.00
$3,851,623,984.00
Revenue This Year
$33.27
$6.12
Revenue Next Year
$50.24
$2.58
P/E Ratio
N/A
$17.57
Revenue Growth
14.90
14.10
52 Week Low
$3.02
$12.26
52 Week High
$8.02
$16.17

Technical Indicators

Market Signals
Indicator
NIO
RDY
Relative Strength Index (RSI) 37.96 44.09
Support Level $4.95 $13.66
Resistance Level $5.38 $14.16
Average True Range (ATR) 0.19 0.15
MACD 0.04 -0.03
Stochastic Oscillator 3.33 30.30

Price Performance

Historical Comparison
NIO
RDY

About NIO NIO Inc. American depositary shares each representing one ordinary share

Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations such as battery swapping and autonomous driving technologies. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 222,000 EVs in 2024, accounting for about 2% of the China passenger new energy vehicle market.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: